1-800-Petmeds,1800Petmeds,Pet Medication Welcome  | Sign In | Reorder | My Account | Contact Us | Cart Shopping Cart
Dogs Cats Horses
  Free Shipping
   
Breath Fresheners
Chews and Treats
Rinses
Toothpaste
Antibiotic Anti-Infective
Cleansers
Mites
Antibiotic Anti-Infective
Eye Inflammation
Glaucoma
Tears Lubricants
Tear Stain Remover
Flea Preventatives
Home Flea Relief
Pet Flea Relief
Heartworm Preventatives
Joint Pain
Joint Supplements
Orthopedic Beds
Allergy
Antibiotics Anti-Infective
Antifungal Antiprotozoal
Anxiety
Cough
Diabetes
Digestive
Diuretics
Heart Blood Pressure
Hormonal Endocrine
Seizure Disorder
Urinary Tract and Kidneys
Weight Loss
Wormers
Pain Medications
Anti-bacterials
First Aid
Fly Control
Grooming Tools
Hairball Remedies
Itch Relief
Omega 3
Ringworm
Shampoos
Shedding
Skin Medications
Supplements
Beds
Bowls
Leashes
Perfumes
Pet Food
Stain Removers
Toys
Training Aids
Treats
Antioxidants
Brewers Yeast
Calcium
Dietary
Digestive Enzymes
Liver Support
Multivitamins
Omega 3
Potassium
Seniors
Whole Foods
   
 

About PetMeds®

Who we are
 
1-800-PetMeds 100% Product Satisfaction Guarantee
 
 
 
 
 
08.13.2003
 
PETMED EXPRESS D/B/A 1-800-PetMeds® APPOINTS A NEW INDEPENDENT DIRECTOR TO ITS BOARD

Pompano Beach, Florida, August 12, 2003 - PetMed Express, Inc. (OTCBB: PETS) today announced the appointment of a new independent board member to its Board of Directors. Joining the PetMed Express Board is Frank Formica. Mr. Formica has spent twenty-nine years in various capacities with the National Association of Securities Dealers (“NASD”), the self-regulatory organization responsible for the regulation of registered broker-dealers in the United States. Leaving the PetMed Express Board is Guven Kivilcim, an inside board member who vacated his seat to support the Company’s goal of creating an independent Board of Directors.

Mendo Akdag, CEO, commented: “We are very pleased with our first quarter results during our peak season. In addition to the sharp increase in sales and profits for the quarter, our reorder sales increased 117%, from $5.8 million to $12.5 million for the three months ended June 30, 2002 and 2003, respectively. We also reported new customer growth of approximately 234,000 customers for the quarter, and approximately 49% of all orders were placed on our website for the quarter in comparison to 39% for the same period prior year.”

“We now have a Board of Directors in which the majority consists of independent members,” said PetMed Express CEO Mendo Akdag. “Mr. Formica, with a long record of accomplishments, brings more diversity and adds a new dimension to our Board of Directors. I would like to welcome our new board member to the Company.”

Frank J. Formica, age 59, has served as a legal consultant and expert in corporate securities and securities industry litigation and arbitration cases since 1999. From 1969 until 1999, Mr. Formica held various positions with NASD including Director of the NASD’s Congressional and State Liaison Department, Director of the Corporate Finance Department, and Vice President and Deputy General Counsel. Mr. Formica received his J.D. degree from the Washington College of Law at American University and an undergraduate degree from Ohio University. He is a member of the New York State Bar.

Mr. Formica has been a frequent speaker in the following programs relating to securities laws and regulations: the American Bar Association; the Practicing Law Institute; the New York Law Institute; the Securities Industry Association; the Real Estate Securities Syndication Institute; the North American Securities Administrators Association; and the NASD compliance conferences.

Founded in 1996, PetMed Express is America’s largest pet pharmacy, delivering prescription and non-prescription pet medications, health and nutritional supplements at competitive prices through the PetMed Express catalog, customer service representatives, and on the Internet through its website at www.1800PetMeds.com

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risk and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis or Plan of Operations in the PetMed Express Annual Report on Form 10-KSB for the year ended March 31, 2003.

For investment relations contact PetMed Express, Inc., Pompano Beach, Mendo Akdag, CEO, 954-979-5995.



Back